Historically a steel production hub, Lehigh Valley will now help manufacture Lilly’s weight loss drug hopeful retatrutide.
The long-held Wall Street expectation that the global market for obesity drugs would reach $150 billion in the next decade is ...
By Maggie Fick, Bhanvi Satija and Mariam Sunny LONDON, Feb 2 (Reuters) - The long-held Wall Street expectation that the ...
By Maggie Fick, Bhanvi Satija and Mariam Sunny LONDON, Feb 2 (Reuters) - The long-held Wall Street expectation that the ...
Falling US prices for GLP-1 weight-loss drugs such as Ozempic, Wegovy and Mounjaro are forcing analysts to rethink long-term ...
Novo Nordisk, the Danish manufacturer of weight-loss drugs Ozempic and Wegovy, has a large market share in the US. But it's ...
22h
Notable healthcare headlines for the week: UnitedHealth, Novo Nordisk, and Thermo Fisher in focus
Wall Street ends week lower as healthcare slides; see top S&P 500 health gainers/losers and key earnings from UNH, NVO, TMO, ...
It’s a tough pill to swallow. There are countless supplements and pantry staples out there that swear to help people slim down, from apple cider vinegar shots to “nature’s Ozempic”. But one popular ...
Pfizer is playing catch-up in the GLP-1 weight-loss space. The drugmaker is getting closer and closer to key patent cliffs.
The Morning Bull - US Market Morning Update Monday, Feb, 2 2026 US stock futures are pointing lower this morning, with E mini S&P 500 contracts down about 0.7% and Nasdaq 100 futures off just over 1%, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results